Roche touts Swiss-led R&D unit after years in Genentech's shadow

Wed, Dec 20, 2017 - 5:50 AM

Zurich

ROCHE is touting prospective new drugs from its long-underperforming Swiss-led research unit after years of leaning on its California-based Genentech arm to restock its medicine cabinet.

This year, the Swiss drugmaker - the top global spender in pharmaceutical research and...

Roche Pharma Research & Early Development
Genentech

Breaking News

02:29 pm

Vietnam criticises China over vessels in disputed waters

02:25 pm

Suspected Japanese arsonist is ex-convict who believed studio stole his novel

02:07 pm

Traders rush away from wagers on a half-point July Fed rate cut

01:52 pm

China Southern Airlines to receive US$4b capital injection

01:33 pm

Iran says British-flagged tanker was in accident with fishing boat

01:13 pm

South Korea targets lawmakers in latest anti-graft proposal

1	Stratech's Chew family is owner of Belmont GCB put up for auction
2	MAS chief data officer David Hardoon moves to newly-created role of special advisor for AI
3	2019 Honda Civic review: Rice to the occasion
4	Smart City Kitchens files competition complaint against GrabFood, Deliveroo
5	SGX to propose scrapping rule on minimum trading price: sources

Consumer

Consumer

You are here

Roche touts Swiss-led R&D unit after years in Genentech's shadow

Singapore remains on radar of China tourists

MAS CDO switches to new role of special adviser in AI

Prime US Reit makes tepid debut to end at IPO price of US$0.88

Must Read

Young and not so upwardly mobile

Singapore remains on radar of China tourists

Surbana Jurong appointed master planner for Nongsa digital economy hub

Efforts to develop workforce for digital economy must include workers from all sectors: Iswaran

You are here

Roche touts Swiss-led R&D unit after years in Genentech's shadow

To continue reading

Market voices on:

Sign up for BT Newsletters

Editor's Choice

Most Read

Must Read